European share prices rise as Brexit concerns ease
Latest polls reveal campaign for Britain to remain in the EU has a one-point lead
Cat allergy flop torpedoes high-profile UK biotech Circassia
Results of the active treatment groups in key clinical study were not significantly better than those on placebo
Ireland’s Malin raises €330m in initial public offering
Life sciences group, set up by a number of ex-Elan executives, surpasses IPO target
State-backed fund expected to back Malin IPO
Britsh fund manager Neil Woodford also purchasing shares
Ireland’s Malin seeks up to €325m in biotech IPO
Former Elan boss Kelly Martin and chairman Bob Ingram to sit on company’s board
More firms weigh IPOs as biotech fever reaches Europe
Top candidates for a share sale include Swiss firms AC Immune and Molecular Partners
Bubble fears grow amid glut of IPOs in the US by early-stage biotechs
Dicerna Pharmaceuticals a focal point of concern as it has yet to enter clinical trials and refused to impose share sale block on major shareholders
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices